{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:36:01Z","timestamp":1787315761381,"version":"build-2736575974"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-025-10565-4","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T20:33:55Z","timestamp":1759264435000},"page":"1499-1523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Phenotype-guided approach for device-based therapies in heart failure"],"prefix":"10.1007","volume":"30","author":[{"given":"Phuuwadith","family":"Wattanachayakul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veraprapas","family":"Kittipibul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca T.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Pinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay S.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Burkhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat","family":"Fudim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"10565_CR1","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jacc.2024.05.061","volume":"84","author":"RT Hahn","year":"2024","unstructured":"Hahn RT, Lindenfeld J, Lim SD et al (2024) Structural Cardiac Interventions in Patients With Heart\u00a0Failure. J Am Coll Cardiol 84:832\u2013847. https:\/\/doi.org\/10.1016\/j.jacc.2024.05.061","journal-title":"J Am Coll Cardiol"},{"key":"10565_CR2","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.cardfail.2024.07.007","volume":"30","author":"JD Estep","year":"2024","unstructured":"Estep JD, Salah HM, Kapadia SR et al (2024) HFSA scientific statement: update on device based therapies in heart failure. J Card Fail 30:1472\u20131488. https:\/\/doi.org\/10.1016\/j.cardfail.2024.07.007","journal-title":"J Card Fail"},{"key":"10565_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-023-00710-2","volume":"11","author":"J Nakata","year":"2023","unstructured":"Nakata J, Yamamoto T, Saku K (2023) Mechanical circulatory support in cardiogenic shock. J Intensive Care 11:64. https:\/\/doi.org\/10.1186\/s40560-023-00710-2","journal-title":"J Intensive Care"},{"key":"10565_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1388232","volume":"11","author":"R Mody","year":"2024","unstructured":"Mody R, Nee Sheth AB, Dash D et al (2024) Device therapies for heart failure with reduced ejection fraction: a new era. Front Cardiovasc Med 11:1388232. https:\/\/doi.org\/10.3389\/fcvm.2024.1388232","journal-title":"Front Cardiovasc Med"},{"key":"10565_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2023.100316","volume":"2","author":"HM Salah","year":"2023","unstructured":"Salah HM, Butler J, Fudim M (2023) Rapid sequence initiation of device therapy in heart failure. JACC Adv 2:100316. https:\/\/doi.org\/10.1016\/j.jacadv.2023.100316","journal-title":"JACC Adv"},{"key":"10565_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/HCO.0000000000001165","volume":"39","author":"F Chouairi","year":"2024","unstructured":"Chouairi F, Levin A, Fudim M (2024) Device therapy for heart failure management. Curr Opin Cardiol 39:465\u2013474. https:\/\/doi.org\/10.1097\/HCO.0000000000001165","journal-title":"Curr Opin Cardiol"},{"key":"10565_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pcad.2024.01.011","volume":"82","author":"F Chouairi","year":"2024","unstructured":"Chouairi F, Levin A, Biegus J, Fudim M (2024) Emerging devices for heart failure management. Prog Cardiovasc Dis 82:125\u2013134. https:\/\/doi.org\/10.1016\/j.pcad.2024.01.011","journal-title":"Prog Cardiovasc Dis"},{"key":"10565_CR8","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.jchf.2023.07.002","volume":"11","author":"HM Salah","year":"2023","unstructured":"Salah HM, Fudim M, Burkhoff D (2023) Device interventions for heart failure. JACC Heart Fail 11:1039\u20131054. https:\/\/doi.org\/10.1016\/j.jchf.2023.07.002","journal-title":"JACC Heart Fail"},{"key":"10565_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006731","volume":"13","author":"H Rosenblum","year":"2020","unstructured":"Rosenblum H, Kapur NK, Abraham WT et al (2020) Conceptual considerations for device-based therapy in acute decompensated heart failure: DRI2P2S. Circ Heart Fail 13:e006731. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.006731","journal-title":"Circ Heart Fail"},{"key":"10565_CR10","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure. J Am Coll Cardiol 79:e263\u2013e421. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012","journal-title":"J Am Coll Cardiol"},{"key":"10565_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jscai.2023.101176","volume":"2","author":"DC Pipilas","year":"2023","unstructured":"Pipilas DC, Hanley A, Singh JP, Mela T (2023) Cardiac contractility modulation for heart failure: current and future directions. J Soc Cardiovasc Angiogr Interv 2:101176. https:\/\/doi.org\/10.1016\/j.jscai.2023.101176","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10565_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2020.05.015","volume":"76","author":"MR Zile","year":"2020","unstructured":"Zile MR, Lindenfeld J, Weaver FA (2020) Baroreflex activation therapy in patients with heart failure with reduced ejection fraction. J Am Coll Cardiol 76:1\u201313. https:\/\/doi.org\/10.1016\/j.jacc.2020.05.015","journal-title":"J Am Coll Cardiol"},{"key":"10565_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F (2022) 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J 43:561\u2013632. https:\/\/doi.org\/10.1093\/eurheartj\/ehab395","journal-title":"Eur Heart J"},{"key":"10565_CR14","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/eurheartj\/ehaa129","volume":"41","author":"PE Bartko","year":"2020","unstructured":"Bartko PE, H\u00fclsmann M, Hung J et al (2020) Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction. Eur Heart J 41:2799\u20132810. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa129","journal-title":"Eur Heart J"},{"key":"10565_CR15","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone GW, Lindenfeld J, Abraham WT et al (2018) Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 379:2307\u20132318. https:\/\/doi.org\/10.1056\/NEJMoa1806640","journal-title":"N Engl J Med"},{"key":"10565_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1421","volume":"373","author":"PE Bartko","year":"2021","unstructured":"Bartko PE, Heitzinger G, Pavo N et al (2021) Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study. BMJ 373:n1421. https:\/\/doi.org\/10.1136\/bmj.n1421","journal-title":"BMJ"},{"key":"10565_CR17","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jcin.2023.01.362","volume":"16","author":"M Adamo","year":"2023","unstructured":"Adamo M, Tomasoni D, Stolz L et al (2023) Impact of transcatheter edge-to-edge mitral valve repair on guideline-directed medical therapy uptitration. JACC Cardiovasc Interv 16:896\u2013905. https:\/\/doi.org\/10.1016\/j.jcin.2023.01.362","journal-title":"JACC Cardiovasc Interv"},{"key":"10565_CR18","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.5664\/jcsm.8076","volume":"15","author":"M Fudim","year":"2019","unstructured":"Fudim M, Spector AR, Costanzo M-R et al (2019) Phrenic nerve stimulation for the treatment of central sleep apnea: a pooled cohort analysis. J Clin Sleep Med 15:1747\u20131755. https:\/\/doi.org\/10.5664\/jcsm.8076","journal-title":"J Clin Sleep Med"},{"key":"10565_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020625","volume":"13","author":"JM Riley","year":"2024","unstructured":"Riley JM, Fradin JJ, Russ DH (2024) Post-capillary pulmonary hypertension: clinical review. J Clin Med 13:625. https:\/\/doi.org\/10.3390\/jcm13020625","journal-title":"J Clin Med"},{"key":"10565_CR20","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","volume":"37","author":"S Rosenkranz","year":"2016","unstructured":"Rosenkranz S, Gibbs JSR, Wachter R et al (2016) Left ventricular heart failure and pulmonary hypertension. Eur Heart J 37:942\u2013954. https:\/\/doi.org\/10.1093\/eurheartj\/ehv512","journal-title":"Eur Heart J"},{"key":"10565_CR21","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.jchf.2023.03.003","volume":"11","author":"S Caravita","year":"2023","unstructured":"Caravita S, Baratto C, Filippo A et al (2023) Shedding light on latent pulmonary vascular disease in heart failure with preserved ejection fraction. JACC: Heart Failure 11:1427\u20131438. https:\/\/doi.org\/10.1016\/j.jchf.2023.03.003","journal-title":"JACC: Heart Failure"},{"issue":"2","key":"10565_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.10.025","volume":"161","author":"A Kadish","year":"2011","unstructured":"Kadish A, Nademanee K, Volosin K (2011) A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J 161(2):e1-2. https:\/\/doi.org\/10.1016\/j.ahj.2010.10.025","journal-title":"Am Heart J"},{"key":"10565_CR23","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jchf.2018.04.010","volume":"6","author":"WT Abraham","year":"2018","unstructured":"Abraham WT, Kuck K-H, Goldsmith RL et al (2018) A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. JACC: Heart Failure 6:874\u2013883. https:\/\/doi.org\/10.1016\/j.jchf.2018.04.010","journal-title":"JACC: Heart Failure"},{"key":"10565_CR24","unstructured":"Impulse Dynamics (2024) Assessment of implantable CCM in the heart failure group with higher ejection fraction. https:\/\/www.cms.gov\/medicarecoverageideapproved-ide-studies\/g200042-nct05064709"},{"key":"10565_CR25","unstructured":"Impulse Dynamics (2024) Assessment of the safety and efficacy of a combined cardiac contractility modulation and implantable cardioverter defibrillator device for subjects with heart failure and reduced ejection fraction.\u00a0https:\/\/clinicaltrials.gov\/study\/NCT05855135"},{"key":"10565_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jscai.2023.101196","volume":"2","author":"MI Brener","year":"2023","unstructured":"Brener MI, Kapadia SR, Burkhoff D (2023) Reverse left ventricular remodeling with transcatheter interventions in chronic heart failure syndromes: an updated appraisal of the device landscape. J Soc Cardiovasc Angiogr Interv 2:101196. https:\/\/doi.org\/10.1016\/j.jscai.2023.101196","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10565_CR27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.hrthm.2023.09.021","volume":"21","author":"D Masarone","year":"2024","unstructured":"Masarone D, Kittleson MM, D\u2019Onofrio A et al (2024) Basic science of cardiac contractility modulation therapy: molecular and electrophysiological mechanisms. Heart Rhythm 21:82\u201388. https:\/\/doi.org\/10.1016\/j.hrthm.2023.09.021","journal-title":"Heart Rhythm"},{"key":"10565_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/17434440.2020.1853525","volume":"18","author":"IV Rao","year":"2021","unstructured":"Rao IV, Burkhoff D (2021) Cardiac contractility modulation for the treatment of moderate to severe HF. Expert Rev Med Devices 18:15\u201321. https:\/\/doi.org\/10.1080\/17434440.2020.1853525","journal-title":"Expert Rev Med Devices"},{"key":"10565_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11247442","volume":"11","author":"D Masarone","year":"2022","unstructured":"Masarone D, Kittleson MM, De Vivo S et al (2022) Effects of cardiac contractility modulation electrodes on tricuspid regurgitation in patients with heart failure with reduced ejection fraction: a pilot study. J Clin Med 11:7442. https:\/\/doi.org\/10.3390\/jcm11247442","journal-title":"J Clin Med"},{"key":"10565_CR30","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1002\/ehf2.14473","volume":"10","author":"JM Molina-Linde","year":"2023","unstructured":"Molina-Linde JM, Cordero-Pereda D, Ba\u00f1os-\u00c1lvarez E et al (2023) Efficacy and safety of baroreflex activation therapy for heart failure with reduced ejection fraction: systematic review. ESC Heart Fail 10:2760\u20132772. https:\/\/doi.org\/10.1002\/ehf2.14473","journal-title":"ESC Heart Fail"},{"key":"10565_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24177","volume":"10","author":"R Shi","year":"2024","unstructured":"Shi R, Sun T, Wang M et al (2024) Baroreflex activation therapy for heart failure with reduced ejection fraction: a comprehensive systematic review and meta-analysis. Heliyon 10:e24177. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24177","journal-title":"Heliyon"},{"key":"10565_CR32","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/ehf2.13242","volume":"8","author":"D Kosevic","year":"2021","unstructured":"Kosevic D, Wiedemann D, Vukovic P et al (2021) Cardio-microcurrent device for chronic heart failure: first-in-human clinical study. ESC Heart Fail 8:962\u2013970. https:\/\/doi.org\/10.1002\/ehf2.13242","journal-title":"ESC Heart Fail"},{"key":"10565_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jacbts.2024.02.008","volume":"9","author":"E Bruckheimer","year":"2024","unstructured":"Bruckheimer E, Rackauskas G, Verheye S et al (2024) Transcatheter pulmonary artery banding for HFrEF. JACC: Basic to Translational Science 9:445\u2013447. https:\/\/doi.org\/10.1016\/j.jacbts.2024.02.008","journal-title":"JACC: Basic to Translational Science"},{"key":"10565_CR34","unstructured":"Study Details | clinical evaluation of the accucinch\u00ae ventricular restoration system in patients who present with symptomatic heart failure with reduced ejection fraction (HFrEF): the CORCINCH-HF study | ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT04331769. Accessed 23 Aug 2024"},{"key":"10565_CR35","unstructured":"Cardiac Dimensions, Inc. (2024) Assessment of the Carillon Mitral Contour System\u00ae in treating heart failure with at least mild functional mitral regurgitation.\u00a0https:\/\/clinicaltrials.gov\/study\/NCT03142152"},{"key":"10565_CR36","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jchf.2024.09.023","volume":"13","author":"JD Estep","year":"2025","unstructured":"Estep JD, Ben-Yehuda O, Wechsler AS et al (2025) Transcatheter Left Ventricular Reconstruction in Heart\u00a0Failure Patients With Prior Anterior Myocardial Infarction. JACC: Heart Failure 13:296\u2013308. https:\/\/doi.org\/10.1016\/j.jchf.2024.09.023","journal-title":"JACC: Heart Failure"},{"key":"10565_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.shj.2022.100103","volume":"6","author":"A Jorbenadze","year":"2022","unstructured":"Jorbenadze A, Goldberg LR, Shaburishvili T (2022) Synchronized diaphragmatic stimulation for heart failure with a reduced left ventricular ejection fraction using the VisONE system: a first-in-patient study with extended population. Struct Heart 6:100103. https:\/\/doi.org\/10.1016\/j.shj.2022.100103","journal-title":"Struct Heart"},{"key":"10565_CR38","unstructured":"Edwards Lifesciences (2024) Early feasibility study of the Edwards APTURE transcatheter shunt system (ALT-FLOW US).\u00a0https:\/\/www.clinicaltrials.gov\/study\/NCT03523416"},{"key":"10565_CR39","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.cardfail.2023.03.003","volume":"29","author":"N Hamid","year":"2023","unstructured":"Hamid N, Jorde UP, Reisman M et al (2023) Transcatheter left ventricular restoration in patients with heart failure. J Card Fail 29:1046\u20131055. https:\/\/doi.org\/10.1016\/j.cardfail.2023.03.003","journal-title":"J Card Fail"},{"key":"10565_CR40","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.jacc.2022.08.760","volume":"80","author":"HM Salah","year":"2022","unstructured":"Salah HM, Goldberg LR, Molinger J et al (2022) Diaphragmatic function in cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol 80:1647\u20131659. https:\/\/doi.org\/10.1016\/j.jacc.2022.08.760","journal-title":"J Am Coll Cardiol"},{"key":"10565_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10741-016-9549-4","volume":"22","author":"RC Kelley","year":"2017","unstructured":"Kelley RC, Ferreira LF (2017) Diaphragm abnormalities in heart failure and aging: mechanisms and integration of cardiovascular and respiratory pathophysiology. Heart Fail Rev 22:191\u2013207. https:\/\/doi.org\/10.1007\/s10741-016-9549-4","journal-title":"Heart Fail Rev"},{"key":"10565_CR42","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/j.jacc.2017.09.006","volume":"70","author":"GA Lewis","year":"2017","unstructured":"Lewis GA, Schelbert EB, Williams SG (2017) Biological phenotypes of heart failure with preserved ejection fraction. J Am Coll Cardiol 70:2186\u20132200. https:\/\/doi.org\/10.1016\/j.jacc.2017.09.006","journal-title":"J Am Coll Cardiol"},{"key":"10565_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.15163","author":"P Wattanachayakul","year":"2024","unstructured":"Wattanachayakul P, Kittipibul V, Salah HM et al (2024) Invasive haemodynamic assessment in heart failure with preserved ejection fraction. ESC Heart Fail. https:\/\/doi.org\/10.1002\/ehf2.15163","journal-title":"ESC Heart Fail"},{"key":"10565_CR44","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2410027","volume":"392","author":"M Packer","year":"2025","unstructured":"Packer M, Zile MR, Kramer CM et al (2025) Tirzepatide for heart failure with preserved ejection fraction and obesity. N Engl J Med 392:427\u2013437. https:\/\/doi.org\/10.1056\/NEJMoa2410027","journal-title":"N Engl J Med"},{"key":"10565_CR45","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41591-024-03374-z","volume":"31","author":"BA Borlaug","year":"2025","unstructured":"Borlaug BA, Zile MR, Kramer CM et al (2025) Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial. Nat Med 31:544\u2013551. https:\/\/doi.org\/10.1038\/s41591-024-03374-z","journal-title":"Nat Med"},{"key":"10565_CR46","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2024.2612","author":"M Fudim","year":"2024","unstructured":"Fudim M, Borlaug BA, Mohan RC et al (2024) Endovascular ablation of the greater splanchnic nerve in heart failure with preserved ejection fraction: the REBALANCE-HF randomized clinical trial. JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2024.2612","journal-title":"JAMA Cardiol"},{"key":"10565_CR47","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/S0140-6736(22)00016-2","volume":"399","author":"SJ Shah","year":"2022","unstructured":"Shah SJ, Borlaug BA, Chung ES et al (2022) Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial. Lancet 399:1130\u20131140. https:\/\/doi.org\/10.1016\/S0140-6736(22)00016-2","journal-title":"Lancet"},{"key":"10565_CR48","unstructured":"Study Details | RESPONDER-HF Trial | ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT05425459. Accessed 13 Sep 2024"},{"key":"10565_CR49","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1161\/CIRCULATIONAHA.124.070870","volume":"150","author":"GW Stone","year":"2024","unstructured":"Stone GW, Lindenfeld J, Rod\u00e9s-Cabau J et al (2024) Interatrial shunt treatment for heart failure: the randomized RELIEVE-HF trial. Circulation 150:1931\u20131943. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.070870","journal-title":"Circulation"},{"key":"10565_CR50","unstructured":"Study Details | Alleviant ALLAY-HF Study | ClinicalTrials.gov.  https:\/\/clinicaltrials.gov\/study\/NCT05685303. Accessed 13 Sep 2024"},{"key":"10565_CR51","unstructured":"Study details | pulmonary artery denervation clinical study using the gradient denervation system in heart failure patients with pulmonary hypertension group 2 (PreVail-PH2 Study) | ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT06052072. Accessed 13 Sep 2024"},{"key":"10565_CR52","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007421","volume":"14","author":"K-P Kresoja","year":"2021","unstructured":"Kresoja K-P, Rommel K-P, Fengler K et al (2021) Renal sympathetic denervation in patients with heart failure with preserved ejection fraction. Circ Heart Fail 14:e007421. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007421","journal-title":"Circ Heart Fail"},{"key":"10565_CR53","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.008301","volume":"14","author":"M Fudim","year":"2021","unstructured":"Fudim M, Sobotka PA, Piccini JP, Patel MR (2021) Renal denervation for patients with heart failure: making a full circle. Circ Heart Fail 14:e008301. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.008301","journal-title":"Circ Heart Fail"},{"key":"10565_CR54","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.jacc.2022.02.050","volume":"79","author":"M Fudim","year":"2022","unstructured":"Fudim M, Kaye DM, Borlaug BA et al (2022) Venous tone and stressed blood volume in heart failure. J Am Coll Cardiol 79:1858\u20131869. https:\/\/doi.org\/10.1016\/j.jacc.2022.02.050","journal-title":"J Am Coll Cardiol"},{"key":"10565_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2025.01.016","author":"HM Salah","year":"2025","unstructured":"Salah HM, Fudim M, Borlaug BA (2025) Changes in stressed blood volume with endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: the REBALANCE-HF trial. J Card Fail. https:\/\/doi.org\/10.1016\/j.cardfail.2025.01.016","journal-title":"J Card Fail"},{"key":"10565_CR56","unstructured":"Duke University (2024) Splanchnic nerve modulation in heart failure (Splanchnic X).\u00a0https:\/\/clinicaltrials.gov\/study\/NCT06733012"},{"key":"10565_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.36628\/ijhf.2021.0038","volume":"4","author":"TH J\u00f8rgensen","year":"2022","unstructured":"J\u00f8rgensen TH, S\u00f8ndergaard L (2022) Transcatheter implantation of interatrial shunt devices to lower left atrial pressure in heart failure. Int J Heart Fail 4:12\u201323. https:\/\/doi.org\/10.36628\/ijhf.2021.0038","journal-title":"Int J Heart Fail"},{"key":"10565_CR58","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.jacc.2019.08.1062","volume":"74","author":"M Obokata","year":"2019","unstructured":"Obokata M, Reddy YNV, Shah SJ et al (2019) Effects of interatrial shunt on pulmonary vascular function in heart failure with preserved ejection fraction. J Am Coll Cardiol 74:2539\u20132550. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.1062","journal-title":"J Am Coll Cardiol"},{"key":"10565_CR59","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1161\/CIRCULATIONAHA.122.059486","volume":"145","author":"BA Borlaug","year":"2022","unstructured":"Borlaug BA, Blair J, Bergmann MW et al (2022) Latent pulmonary vascular disease may alter the response to therapeutic atrial shunt device in heart failure. Circulation 145:1592\u20131604. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.059486","journal-title":"Circulation"},{"key":"10565_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.101776","volume":"48","author":"AM Salazar","year":"2023","unstructured":"Salazar AM, Al-Asad KS, Prasad RM et al (2023) Pulmonary artery denervation as a new therapeutic option for pulmonary hypertension: a systematic review and meta-analysis. Curr Probl Cardiol 48:101776. https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101776","journal-title":"Curr Probl Cardiol"},{"key":"10565_CR61","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/ejhf.3187","volume":"26","author":"C Gerges","year":"2024","unstructured":"Gerges C, Vollmers K, Skoro-Sajer N et al (2024) Efficacy and safety of the Aria pulmonary endovascular device in pulmonary hypertension. Eur J Heart Fail 26:686\u2013694. https:\/\/doi.org\/10.1002\/ejhf.3187","journal-title":"Eur J Heart Fail"},{"key":"10565_CR62","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12928-022-00898-4","volume":"38","author":"A Kataoka","year":"2023","unstructured":"Kataoka A, Watanabe Y (2023) Mitraclip: a review of its current status and future perspectives. Cardiovasc Interv Ther 38:28\u201338. https:\/\/doi.org\/10.1007\/s12928-022-00898-4","journal-title":"Cardiovasc Interv Ther"},{"key":"10565_CR63","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/CIR.0000000000000932","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO et al (2021) 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation 143:e35\u2013e71. https:\/\/doi.org\/10.1161\/CIR.0000000000000932","journal-title":"Circulation"},{"key":"10565_CR64","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jcmg.2024.01.012","volume":"17","author":"L Stolz","year":"2024","unstructured":"Stolz L, Doldi PM, Sannino A et al (2024) The evolving concept of secondary mitral regurgitation phenotypes. JACC Cardiovasc Imaging 17:659\u2013668. https:\/\/doi.org\/10.1016\/j.jcmg.2024.01.012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10565_CR65","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1016\/j.jcin.2024.08.031","volume":"17","author":"CP Huded","year":"2024","unstructured":"Huded CP, Chhatriwalla AK, Shah MA et al (2024) Mitral transcatheter edge-to-edge repair for secondary mitral regurgitation with preserved left ventricular function. JACC Cardiovasc Interv 17:2515\u20132526. https:\/\/doi.org\/10.1016\/j.jcin.2024.08.031","journal-title":"JACC Cardiovasc Interv"},{"key":"10565_CR66","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/j.jcmg.2022.05.009","volume":"15","author":"P Doldi","year":"2022","unstructured":"Doldi P, Stolz L, Orban M et al (2022) Transcatheter mitral valve repair in patients with atrial functional mitral regurgitation. JACC Cardiovasc Imaging 15:1843\u20131851. https:\/\/doi.org\/10.1016\/j.jcmg.2022.05.009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10565_CR67","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jacc.2015.02.009","volume":"65","author":"AW Asgar","year":"2015","unstructured":"Asgar AW, Mack MJ, Stone GW (2015) Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol 65:1231\u20131248. https:\/\/doi.org\/10.1016\/j.jacc.2015.02.009","journal-title":"J Am Coll Cardiol"},{"key":"10565_CR68","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1056\/NEJMoa2300213","volume":"388","author":"GW Stone","year":"2023","unstructured":"Stone GW, Abraham WT, Lindenfeld J et al (2023) Five-year follow-up after transcatheter repair of secondary mitral regurgitation. N Engl J Med 388:2037\u20132048. https:\/\/doi.org\/10.1056\/NEJMoa2300213","journal-title":"N Engl J Med"},{"key":"10565_CR69","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","volume":"379","author":"J-F Obadia","year":"2018","unstructured":"Obadia J-F, Messika-Zeitoun D, Leurent G et al (2018) Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 379:2297\u20132306. https:\/\/doi.org\/10.1056\/NEJMoa1805374","journal-title":"N Engl J Med"},{"key":"10565_CR70","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.21037\/jtd.2020.01.67","volume":"12","author":"F Nappi","year":"2020","unstructured":"Nappi F, Nenna A, Sing SSA et al (2020) Mitral regurgitation: lessons learned from COAPT and MITRA-Fr. J Thorac Dis 12:2936\u20132944. https:\/\/doi.org\/10.21037\/jtd.2020.01.67","journal-title":"J Thorac Dis"},{"key":"10565_CR71","unstructured":"Montreal Heart Institute (2019) Evaluation of outcomes of transcatheter mitral valve repair for the treatment of low ejection fraction and moderate functional mitral valve regurgitation in heart failure.\u00a0https:\/\/clinicaltrials.gov\/study\/NCT02985268"},{"key":"10565_CR72","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1056\/NEJMoa2300525","volume":"388","author":"P Sorajja","year":"2023","unstructured":"Sorajja P, Whisenant B, Hamid N et al (2023) Transcatheter repair for patients with tricuspid regurgitation. N Engl J Med 388:1833\u20131842. https:\/\/doi.org\/10.1056\/NEJMoa2300525","journal-title":"N Engl J Med"},{"key":"10565_CR73","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa2401918","volume":"392","author":"RT Hahn","year":"2025","unstructured":"Hahn RT, Makkar R, Thourani VH et al (2025) Transcatheter valve replacement in severe tricuspid regurgitation. N Engl J Med 392:115\u2013126. https:\/\/doi.org\/10.1056\/NEJMoa2401918","journal-title":"N Engl J Med"},{"key":"10565_CR74","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1056\/NEJMoa2314328","volume":"391","author":"SD Anker","year":"2024","unstructured":"Anker SD, Friede T, von Bardeleben R-S et al (2024) Transcatheter valve repair in heart failure with moderate to severe mitral regurgitation. N Engl J Med 391:1799\u20131809. https:\/\/doi.org\/10.1056\/NEJMoa2314328","journal-title":"N Engl J Med"},{"key":"10565_CR75","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/j.jacc.2024.08.027","volume":"84","author":"P Ponikowski","year":"2024","unstructured":"Ponikowski P, Friede T, von Bardeleben RS et al (2024) Hospitalization of symptomatic patients with heart failure and moderate to severe functional mitral regurgitation treated with MitraClip: insights from RESHAPE-HF2. J Am Coll Cardiol 84:2347\u20132363. https:\/\/doi.org\/10.1016\/j.jacc.2024.08.027","journal-title":"J Am Coll Cardiol"},{"key":"10565_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2025.02.004","author":"P von Stein","year":"2025","unstructured":"von Stein P, Iliadis C (2025) Transcatheter edge-to-edge repair for mitral regurgitation. Trends Cardiovasc Med. https:\/\/doi.org\/10.1016\/j.tcm.2025.02.004","journal-title":"Trends Cardiovasc Med"},{"key":"10565_CR77","unstructured":"Medtronic Cardiovascular (2025) Transcatheter mitral valve replacement with the Medtronic IntrepidTM TMVR system in patients with severe symptomatic mitral regurgitation - APOLLO trial.\u00a0https:\/\/www.clinicaltrials.gov\/study\/NCT03242642"},{"key":"10565_CR78","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/eurheartj\/ehy641","volume":"40","author":"N Wang","year":"2019","unstructured":"Wang N, Fulcher J, Abeysuriya N et al (2019) Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. Eur Heart J 40:476\u2013484. https:\/\/doi.org\/10.1093\/eurheartj\/ehy641","journal-title":"Eur Heart J"},{"key":"10565_CR79","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032999","volume":"13","author":"M Ambrosino","year":"2024","unstructured":"Ambrosino M, Sangoi M, Monzer N (2024) Tricuspid regurgitation: a review of current interventional management. J Am Heart Assoc 13:e032999. https:\/\/doi.org\/10.1161\/JAHA.123.032999","journal-title":"J Am Heart Assoc"},{"key":"10565_CR80","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1056\/NEJMra2216709","volume":"388","author":"RT Hahn","year":"2023","unstructured":"Hahn RT (2023) Tricuspid regurgitation. N Engl J Med 388:1876\u20131891. https:\/\/doi.org\/10.1056\/NEJMra2216709","journal-title":"N Engl J Med"},{"key":"10565_CR81","doi-asserted-by":"publisher","first-page":"57","DOI":"10.14797\/mdcvj.1250","volume":"19","author":"CM Barker","year":"2023","unstructured":"Barker CM, Goel K (2023) Transcatheter tricuspid interventions: past, present, and future. Methodist Debakey Cardiovasc J 19:57\u201366. https:\/\/doi.org\/10.14797\/mdcvj.1250","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10565_CR82","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jacc.2024.10.086","volume":"85","author":"GHL Tang","year":"2025","unstructured":"Tang GHL, Hahn RT, Whisenant BK et al (2025) Tricuspid transcatheter edge-to-edge repair for severe tricuspid regurgitation: 1-year outcomes from the TRILUMINATE randomized cohort. J Am Coll Cardiol 85:235\u2013246. https:\/\/doi.org\/10.1016\/j.jacc.2024.10.086","journal-title":"J Am Coll Cardiol"},{"key":"10565_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2025.04.008","volume":"13","author":"RT Hahn","year":"2025","unstructured":"Hahn RT, Adamo M, Fam NP (2025) Current evidence on tricuspid regurgitation interventions in heart failure. JACC Heart Fail 13:102493. https:\/\/doi.org\/10.1016\/j.jchf.2025.04.008","journal-title":"JACC Heart Fail"},{"key":"10565_CR84","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1378\/chest.06.2287","volume":"131","author":"DJ Eckert","year":"2007","unstructured":"Eckert DJ, Jordan AS, Merchia P, Malhotra A (2007) Central sleep apnea. Chest 131:595\u2013607. https:\/\/doi.org\/10.1378\/chest.06.2287","journal-title":"Chest"},{"key":"10565_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101364","volume":"47","author":"M Fudim","year":"2022","unstructured":"Fudim M, Shahid I, Emani S (2022) Evaluation and treatment of central sleep apnea in patients with heart failure. Curr Probl Cardiol 47:101364. https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101364","journal-title":"Curr Probl Cardiol"},{"key":"10565_CR86","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S0140-6736(16)30961-8","volume":"388","author":"MR Costanzo","year":"2016","unstructured":"Costanzo MR, Ponikowski P, Javaheri S et al (2016) Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial. Lancet 388:974\u2013982. https:\/\/doi.org\/10.1016\/S0140-6736(16)30961-8","journal-title":"Lancet"},{"key":"10565_CR87","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jchf.2014.12.013","volume":"3","author":"WT Abraham","year":"2015","unstructured":"Abraham WT, Jagielski D, Oldenburg O et al (2015) Phrenic nerve stimulation for the treatment of central sleep apnea. JACC: Heart Failure 3:360\u2013369. https:\/\/doi.org\/10.1016\/j.jchf.2014.12.013","journal-title":"JACC: Heart Failure"},{"key":"10565_CR88","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/ehf2.15074","volume":"12","author":"WT Abraham","year":"2024","unstructured":"Abraham WT, Oldenburg O, Lainscak M et al (2024) Win ratio analysis of transvenous phrenic nerve stimulation to treat central sleep apnoea in heart failure. ESC Heart Fail 12:80\u201386. https:\/\/doi.org\/10.1002\/ehf2.15074","journal-title":"ESC Heart Fail"},{"key":"10565_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12196200","volume":"12","author":"EA Kobe","year":"2023","unstructured":"Kobe EA, McVeigh T, Hameed I, Fudim M (2023) Heart failure remote monitoring: a review and implementation how-to. J Clin Med 12:6200. https:\/\/doi.org\/10.3390\/jcm12196200","journal-title":"J Clin Med"},{"key":"10565_CR90","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s10741-024-10426-6","volume":"29","author":"P Wattanachayakul","year":"2024","unstructured":"Wattanachayakul P, Kittipibul V, Salah HM et al (2024) Non-invasive heart failure monitoring: leveraging smart scales and digital biomarkers to improve heart failure outcomes. Heart Fail Rev 29:1145\u20131156. https:\/\/doi.org\/10.1007\/s10741-024-10426-6","journal-title":"Heart Fail Rev"},{"key":"10565_CR91","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","volume":"377","author":"WT Abraham","year":"2011","unstructured":"Abraham WT, Adamson PB, Bourge RC et al (2011) Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377:658\u2013666. https:\/\/doi.org\/10.1016\/S0140-6736(11)60101-3","journal-title":"Lancet"},{"key":"10565_CR92","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(21)01754-2","volume":"398","author":"J Lindenfeld","year":"2021","unstructured":"Lindenfeld J, Zile MR, Desai AS et al (2021) Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. Lancet 398:991\u20131001. https:\/\/doi.org\/10.1016\/S0140-6736(21)01754-2","journal-title":"Lancet"},{"key":"10565_CR93","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0140-6736(23)00923-6","volume":"401","author":"JJ Brugts","year":"2023","unstructured":"Brugts JJ, Radhoe SP, Clephas PRD et al (2023) Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial. Lancet 401:2113\u20132123. https:\/\/doi.org\/10.1016\/S0140-6736(23)00923-6","journal-title":"Lancet"},{"issue":"24","key":"10565_CR94","doi-asserted-by":"publisher","first-page":"00485","DOI":"10.1016\/j.jchf.2024.05.017","volume":"S2213\u20131779","author":"JL Guichard","year":"2024","unstructured":"Guichard JL, Bonno EL, Nassif ME et al (2024) Seated pulmonary artery pressure monitoring in patients with heart failure: results of the PROACTIVE-HF trial. JACC Heart Fail S2213\u20131779(24):00485\u201300492. https:\/\/doi.org\/10.1016\/j.jchf.2024.05.017","journal-title":"JACC Heart Fail"},{"key":"10565_CR95","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.010012","volume":"16","author":"M Fudim","year":"2023","unstructured":"Fudim M, Yazdi D, Egolum U (2023) Use of a cardiac scale to predict heart failure events: design of SCALE-HF 1. Circ Heart Fail 16:e010012. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.122.010012","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10565_CR96","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.cardfail.2019.11.007","volume":"25","author":"WT Abraham","year":"2019","unstructured":"Abraham WT, Anker S, Burkhoff D (2019) Primary results of the Sensible Medical Innovations lung fluid status monitor allows reducing readmission rate of heart failure patients (smile) trial. J Card Fail 25:938. https:\/\/doi.org\/10.1016\/j.cardfail.2019.11.007","journal-title":"J Card Fail"},{"issue":"24","key":"10565_CR97","doi-asserted-by":"publisher","first-page":"00616","DOI":"10.1016\/j.jchf.2024.07.022","volume":"S2213\u20131779","author":"JP Boehmer","year":"2024","unstructured":"Boehmer JP, Cremer S, Abo-Auda WS et al (2024) Impact of a novel wearable sensor on heart failure rehospitalization: an open-label concurrent-control clinical trial. JACC Heart Fail S2213\u20131779(24):00616\u201300624. https:\/\/doi.org\/10.1016\/j.jchf.2024.07.022","journal-title":"JACC Heart Fail"},{"key":"10565_CR98","unstructured":"NHS Greater Glasgow and Clyde (2023) Correlation of the non-invasive cardiopulmonary management (CPM) wearable device with measures of congestion in heart failure.\u00a0https:\/\/clinicaltrials.gov\/study\/NCT05026034?tab=table"},{"key":"10565_CR99","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1093\/eurheartj\/ehad346","volume":"44","author":"PRD Clephas","year":"2023","unstructured":"Clephas PRD, Radhoe SP, Boersma E et al (2023) Efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure: a meta-analysis of three randomized controlled trials. Eur Heart J 44:3658\u20133668. https:\/\/doi.org\/10.1093\/eurheartj\/ehad346","journal-title":"Eur Heart J"},{"key":"10565_CR100","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jacc.2023.11.030","volume":"83","author":"J Lindenfeld","year":"2024","unstructured":"Lindenfeld J, Costanzo MR, Zile MR et al (2024) Implantable hemodynamic monitors improve survival in patients with heart failure and reduced ejection fraction. J Am Coll Cardiol 83:682\u2013694. https:\/\/doi.org\/10.1016\/j.jacc.2023.11.030","journal-title":"J Am Coll Cardiol"},{"key":"10565_CR101","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","volume":"81","author":"MM Kittleson","year":"2023","unstructured":"Kittleson MM, Panjrath GS, Amancherla K et al (2023) 2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 81:1835\u20131878. https:\/\/doi.org\/10.1016\/j.jacc.2023.03.393","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10565-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-025-10565-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10565-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:04:10Z","timestamp":1763154250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-025-10565-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":101,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10565"],"URL":"https:\/\/doi.org\/10.1007\/s10741-025-10565-4","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Fudim was supported by the NIH, Bodyport, Sardocor, and Doris Duke. He is a consultant\/has ownership interesting in Abbott, Ajax, Alio Health, Alleviant, Analog, Andera, Artha, Audicor, AxonTherapies, Bayer, Bodyguide, Bodyport, Boston Scientific, Broadview, Cadence, Cardioflow, Coridea, CVRx, Daxor, Edwards LifeSciences, Echosens, EKO, Feldschuh Foundation, Fire1, FutureCardia, Galvani, Gradient, Hatteras, HemodynamiQ, Impulse Dynamics, Intershunt, Medtronic, Merck, NIMedical, NovoNordisk, NucleusRx, NXT Biomedical, Orchestra, Pharmacosmos, Presidio, Procyreon, Proton Intelligence, ReCor, Rockley, SCPharma, Shifamed, Splendo, STAT Health, Summacor, SyMap, Verily, Vironix, Viscardia, and Zoll. Dr Burkhoff has received speaker honorarium from Abiomed\/Johnson and Johnson; receives institutional support from Ancora Heart; is a consultant to Corvia Medical, Impulse Dynamics, Orchestra Biomedical, and Zoll Medical Corp; and a minor shareholder in Aquapass, Orchestra Biomedical, and Xenter. Dr Hahn reports speaker fees from Abbott Structural, Baylis Medical, Edwards Lifesciences, and Philips Healthcare; she has institutional consulting contracts for which she receives no direct compensation with Abbott Structural, Anteris, Boston Scientific, Edwards Lifesciences, Medtronic, Novartis, and Philips Healthcare. Dr Pinney was supported by Abbott, ADI, Ancora, CareDx, Cordio, Medtronic, Nuwellis, Restore Medical, Transmedics, and Valgen Medtech. Dr Abraham reports consulting fees from Abbott, AquaPass, Cordio, CVRx, Innoventric, Relief Cardiovascular, Sensible Medical, Vectorious, WhiteSwell, and Zoll Respicardia; speaker honoraria from Impulse Dynamics; and holds leadership roles as a member of the Board of Directors at scPharmaceuticals and as Medical Director at JNJ V-Wave. Dr Desai has received research grants from Bayer, Abbott, Alnylam, AstraZeneca, and Novartis. He has also received consulting fees from Bayer, Abbott, Alnylam, AstraZeneca, Avidity Biopharma, Axon Therapeutics, Biofourmis, Boston Scientific, Endotronix, GlaxoSmithKline, Medpace, Medtronic, Merck, New Amsterdam, Novartis, Parexel, Regeneron, Roche, River2Renal, scPharmaceuticals, Veristat, Verily, and Zydus, all outside the submitted work. All other authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}